Abstract
Background and aims
Enterococci are Gram-positive cocci that often occur in pairs (diplococci) or short chains. Be-side developing high level of antibiotic resistance, these bacteria can cause wide range of disease in human, thus to help provide an effective treatment for infections caused by this genus, this study was conceived to provide information on Enterococcus faecalis Antibiotic resistance to widely used antibiotics in hospitalized patients.
Materials and methods
Disk diffusion agar and Broth dilution methods were used to perform Antibiogram test on isolated Enterococcus faecalis. Culture medium used for Disk diffusion agar test was Muller Hinton agar, and for Broth dilution methods, Muller Hinton broth culture medium was utilized. In disk diffusion agar method, different commercial antibiotics disks produced by Pharmaceutical companies were used. Microsoft Excel software was used to perform statistical analysis.
Results
Based on antibiograms of 105 cases, a high resistance to Synercid, Nalidixic acid, Oxacillin and Teofilin was de-tected whereas the lowest resistance observed in Nitrofurantoin, Vancomycin, Linezolid and Teicoplanin antibiotics.
Conclusion
According to the results, Teicoplanin, Vancomycin, Linezolid and Nitrofurantoin are recommended against E. faecalis species.
Keywords: Antibiogram, Enterococcus faecalis, MIC
Introduction
Enterococci are Gram-positive cocci that commensal inhabitants of the human intestine. Some strains of this genus have developed resistance to antibiotics.1 These bacteria are non-motile, without capsule and cultivated on the bile esculin agar (BEA) as a selective differential medium. Enterococcus growths fast in 37-42°C temperature and forms non-hemolytic colonies.2 Members of the genus Enterococcus are capable of growing in the presence of 6.5% NaCl and 4% bile (oxgall) and hydrolyzing esculin to glucose and esculetin. Esculetin combines with ferric ions to produce a black complex.2 Important clinical infections caused by Enterococcus include urinary tract infections, bacteremia, bacterial endocarditis, diverticulitis, and meningitis. They can tolerate 60°C heat for 30 minutes.3-5
This study was conceived to provide information on Enterococcus faecalis Antibiotic resistance to widely used antibiotics in hospitalized patients, considering dose and their type.
Materials and Methods
One-hundred and five samples were collected from patients hospitalized with enterococcus infections in Tabriz, Iran, from March 2012 to the end of June 2012.
The most simple and best methods for antibiogram are preparation tubular tenuityies and disk diffusion agar. Bacterial suspensions with McFarland Standard 0.5% were cultured in Mueller-Hinton agar medium and impregnated paper disks were placed on the culture medium.2,30.5% McFarland standard was prepared by mixing 0.05 ml of 1.175% barium chloride dihydrate (BaCl2•2H2O), with 9.95 ml of 1% sulfuric acid (H2SO4). The mixture was confirmed by spectrophotometer at 625 nm wave length. The absorbency for 0.5% McFarland standard must be in 0.1-0.68 range. The standards are equivalent to 1-1.5×108 bacteria in milliliter.
The antibiotic disks used for antibiogram test included Vancomycin (30 mg), Nalidixic Acid (30 mg), Ampicillin (10 mg), Nitrofurantoin (300 mg), Oxacillin (1mg), Tetracycline (30 mg), Gentamicin (100 mg), Co-trimoxazole (1.25-22.75), Erythromycin (30 mg), Teicoplanin (30mg), Linezolid (30 mg), Ciprofloxacin, Synercid, Doxycycline.
After 24 hours of incubation in 37°C, the inhibition zone was measured with metric ruler and then matched with NCCLS (National Committee for Clinical Laboratory Standards) tables to finalize antimicrobial susceptibility tests.
Minimum inhibitory concentration (MIC) was used to determine antimicrobial resistance.
Antibiotic with different concentrations were prepared from antibiotic solution. 1,6,712 sterile tubes in the form of tower row triplet and added 1, 3 and 7 ml Muller Hinton broth culture environment to first, second, and third rows, respectively. Then, we added 1 ml of antibiotic solution to three first rows. 3 ml was taken from the third tube and added 1 ml to second row of triplet tube. After mixing, 3 ml was taken from sixth tube again, and 1 ml was added to the third row of triplet tubes. Again 3 ml was taken from ninth tube and 1 ml was added to the fourth row of triplet tubes. Accordingly, antibiotic concentrations were prepared in tubes 1 to 12 as 1024, 512, 256, 128, 64, 32, 16, 8, 4, 2, 1, 0.5, and 0.25, respectively. 1 ml of each concentrations was poured in the 12 sterile tubes and then bacterium suspensions were added (0.5 McFarland 100 land and 19.9 ml Muller Hinton broth environment). There are 1.5×108 bacteria in each milliliter, and 1 ml was added to each of the 12 tubes. Then, the tubes were placed in incubator at 37°C for 24 hours.6,8 The development of opacity in the tubes indicated bacterial resistance. MIC is the case antibiotic.8,9To determine resistance percentage and distinguish multi-resistance lineage of Enterococcus faecalis isolated from patients Microsoft Excel software was used.
Results
Based on antibiograms of 105 subjects, the presence of antibiotic-resistance was more prevalently observed with Tetracycline, Oxacillin and Nalidixic Acid. Also, a 100% resistance was observed in the case of Synercid. Percentage of enterococcus antibiotic-resistance to different antibiotics is shown in the Table 1.
Table 1. Percentage of resistant enterococci to different antibiotics.
Antibiotics | Synercid | Nalidixic acid | Oxacillin | Teicoplanin | Ciprofloxacin | Doxycycline | Ampicillin | Gentamycin | Erythromycin | Amikacin | chloramphenicol | Nitrofurantoin | Linezolid | Vancomycin | Teicoplanin |
Resistant (%) | 100 | 94 | 93 | 83 | 44 | 44 | 4 | 36.2 | 29 | 27 | 2 | 18.6 | 5.1 | 3.6 | 3.3 |
Discussion
For effective treatment of bacterial infections, adequate concentration of antibiotic must be present in the site of infection. This concentration must show either bactericidal or bacteriostatic activity against susceptible bacteria. Therefore, if in a case, the level of antibiotic required for preventing bacteria from growing, exceeds toxic concentrations, the bacterium is considered antibiotic-resistant.
Enterococcus faecalis is Gram-positive cocci that often in the form of diplococci or short chains. E. faecalis can cause endocarditis and bacteremia, urinary tract infections (UTI), meningitis, and other infections in humans. This species can grow in bile esculin agar and environments with 6.5% NaCl. It growths fast at 37-42°C temperature while it can tolerate 60°C heat for 30 minutes.
Recent reports show that resistance of these bacteria to commonly used antibiotics is increasing worldwide. Even Vancomycin-resistant and Gentamicin-resistant species of E. faecalis are reported.10,11 An antibiogram test is, hence, required for effective treatment. In the present study, the highest rate of resistance was seen with Synercid (100%). For Nalidixic acid, resistant was 94% and for Oxacillin it was about 93%. Also about 83% of cases showed resistance to Teofilin which is regarded a high resistance. These antibiotics cannot be appropriate prescriptions for the treatment of E. faecalis infections. Moderate resistance was reported in Ciprofloxacin, Doxycycline, Amikacin, Gentamycin, and the least percentage of resistance was obtained with Teicoplanin, Vancomycin, Linezolid, and Nitrofurantoin.
According to the results, it can be concluded that instead of prescribing antibiotics like Gentamycin, Amikacin or Oxacillin against E. faecalis infection, antibiotics like Teicoplanin, Vancomycin, Linezolid, and Nitrofurantoin are recommended along with antibiotics like chloramphenicol and Ampicillin as the second-line agents.
References
- 1.Jawetz E, Melnich JLL, Adelberg EA. Medical Microbiology LANGE. 21st ed. California: Mc Grow Hill; 2001. 43-8 [Google Scholar]
- 2.Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 12th ed. St Louis: Mosby; 2007. 101-10 [Google Scholar]
- 3.Shankar N, Lockatell CV, Baghdayan AS, Drachenberg C, Gilmore MS, Johnson DE. Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun . 2001;69:4366–72. doi: 10.1128/IAI.69.7.4366-4372.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Benca J, Ondrusova A, Huttova M, Rudinsky B, Kisac P, Bauer F. Neuroinfections due to Enterococcus faecalis in children. Neuro Endocrinol Lett . 2007;28:32–3. [PubMed] [Google Scholar]
- 5.Zoletti GO, Pereira EM, Schuenck RP, Teixeira LM, Siqueira JF Jr, dos Santos KR. Characterization of virulence factors and clonal diversity of Enterococcus faecalis isolates from treated dental root canals. Res Microbiol . 2011;162:151–8. doi: 10.1016/j.resmic.2010.09.018. [DOI] [PubMed] [Google Scholar]
- 6.Grant SG, Jessee J, Bloom FR, Hanahan D. Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc Natl Acad Sci USA . 1990;87:4645–9. doi: 10.1073/pnas.87.12.4645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Marrag PR, Rosental KS, Kobayashi GS, Pfaller MA. Medical Microbiology. 4th ed. St Louis: Mosby; 2002. 45-8 [Google Scholar]
- 8.Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis . 2006;42:525–34. doi: 10.1086/491711. [DOI] [PubMed] [Google Scholar]
- 9.Kousedghi H, Ahangari Z, Eslami G, Ayatolahi A. Antibacterial activity of propolis and Ca (OH) 2 against Lactobacillus, Entrococus facalis, Peptostreptococus and Candida albicans. African Journal of Microbiology Research . 2012;14:3510–5. [Google Scholar]
- 10.Aligholi M, Emaneini M, Taherikalani M, Shahsavan S, Jabalameli F, Asadollahi P. et al. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium. Acta Microbiol Immunol Hung . 2011;58:219–26. doi: 10.1556/AMicr.58.2011.3.5. [DOI] [PubMed] [Google Scholar]
- 11.Furustrand Tafin U, Majic I, Zalila Belkhodja C, Betrisey B, Corvec S, Zimmerli W. et al. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother . 2011;55:4821–7. doi: 10.1128/AAC.00141-11. [DOI] [PMC free article] [PubMed] [Google Scholar]